U.S. markets open in 9 hours 30 minutes
  • S&P Futures

    3,718.00
    +27.75 (+0.75%)
     
  • Dow Futures

    29,730.00
    +192.00 (+0.65%)
     
  • Nasdaq Futures

    11,389.25
    +103.50 (+0.92%)
     
  • Russell 2000 Futures

    1,731.40
    +16.50 (+0.96%)
     
  • Crude Oil

    83.92
    +0.29 (+0.35%)
     
  • Gold

    1,707.90
    +5.90 (+0.35%)
     
  • Silver

    20.93
    +0.35 (+1.68%)
     
  • EUR/USD

    0.9845
    +0.0018 (+0.19%)
     
  • 10-Yr Bond

    3.6510
    -0.1530 (-4.02%)
     
  • Vix

    30.10
    -1.52 (-4.81%)
     
  • GBP/USD

    1.1319
    -0.0001 (-0.01%)
     
  • USD/JPY

    144.7200
    +0.1000 (+0.07%)
     
  • BTC-USD

    19,591.59
    +415.75 (+2.17%)
     
  • CMC Crypto 200

    445.83
    +10.47 (+2.41%)
     
  • FTSE 100

    6,908.76
    +14.95 (+0.22%)
     
  • Nikkei 225

    26,921.18
    +705.39 (+2.69%)
     

Neupath Health Announces Issuance of Stock Options

·1 min read

TORONTO, August 26, 2022--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), ("NeuPath" or the "Company"), owner and operator of a network of clinics delivering category-leading chronic pain treatment, announced today that, in relation to the executive changes announced on July 25, 2022, a grant of 965,000 stock options ("Options") to certain officers of the Company at an exercise price of $0.30 per share, with an expiry date of August 24, 2029. The Options are subject to time-based vesting such that 1/3 vests immediately, 1/3 vests on January 22, 2023 and the remaining Options will vest on July 21, 2023. The terms of the Options granted are in accordance with the Company’s Amended and Restated Stock Option Plan.

About NeuPath

NeuPath is a vertically integrated health care provider utilizing research, data-driven insights, technology, and interdisciplinary care to help restore function for patients impacted by chronic pain, spinal injuries, sport-related injuries, and concussions. With equity ownership in seventeen clinics in Ontario and Alberta, NeuPath is building out a large-scale network to better serve patients across Canada. NeuPath is focused on transforming the hope of a better life into the reality of a life more fully lived.

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future including, without limitation, the execution of the Company’s expansion strategy in 2022, are forward-looking statements. These forward-looking statements reflect the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company. Factors that could cause actual results or events to differ materially from current expectations included in this news release include, among other things, the severity, duration and spread of the COVID-19 outbreak, as well as its direct and indirect impacts that the pandemic may have on the Company’s operations, adverse market conditions, risks associated with obtaining and maintaining the necessary governmental permits and licenses related to the business of the Company, increasing competition in the market and other risks generally inherent in the chronic pain, sports medicine, concussion and workplace health services markets. A comprehensive discussion of these and other risks and uncertainties can be found in the Company’s annual information form dated March 17, 2022 filed on SEDAR under the Company’s profile at www.sedar.com.

Any forward-looking statement speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking statement, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions underlying the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and accordingly undue reliance should not be put on such statements due to their inherent uncertainty.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS THE RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220826005414/en/

Contacts

Jeff Zygouras
info@neupath.com
(905) 858-1368